TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

TUXEDO trial, diabetic patients, drug-eluting stents, everolimus, paclitaxel, TCT 2015

Image courtesy of Abbott Vascular

News | Stents Drug Eluting | October 23, 2015
October 23, 2015 — Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found...
RIVER-PCI trial, ranolazine, incomplete revascularization, ICR, post-PCI, TCT 2015
News | Antiplatelet and Anticoagulation Therapies | October 23, 2015
October 23, 2015 — A randomized trial found that ranolazine did not reduce the composite rate of ischemia-driven...
Medtronic CoreValve, real-world clinical outcomes, STS/ACC TVT Registry, TCT 2015

Image courtesy of Medtronic

News | Heart Valve Technology | October 22, 2015
October 22, 2015 — Medtronic plc released the first CoreValve transcatheter aortic valve replacement (TAVR) system...
News | Stents | October 22, 2015
October 22, 2015 — Results from the LEADERS FREE trial found that a polymer-free drug-coated stent (DCS) was superior...
ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis

Image courtesy of Medtronic

Feature | Drug-Eluting Balloons | October 22, 2015
October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated...
Direct Flow Medical TAVR System, DISCOVER post-market study, real-world results, TCT 2015

Image courtesy of Direct Flow Medical Inc.

News | Heart Valve Technology | October 22, 2015
October 22, 2015 — Direct Flow Medical Inc. announced one-year outcomes from the DISCOVER post-market study that...
thrombus aspiration, STEMI patients, TCT 2015, TOTAL study
Feature | Thrombectomy Devices | October 20, 2015
October 20, 2015 — A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT)...
BRAVO 3 trial results, bivalirudin, heparin, anticoagulation, TAVR, TCT 2015
Feature | Antiplatelet and Anticoagulation Therapies | October 20, 2015
October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding...
Amaranth Fortitute Bioresorbable stent

The Amaranth Fortitute bioresorbable stent was among several fully bioresorbing platforms discussed in sessions, late breaking trial data presentations and on the expo floor at TCT 2015.

Feature | TCT | October 19, 2015 | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT)...
transradial access, TRI, DRAGON trial, TCT 2015, non-inferiority, transfemoral access, TFO
Feature | Radial Access | October 18, 2015
October 18, 2015 — Results from a prospective randomized trial of transradial (TRI) versus transfemoral (TFO) access in...
FFR-CT, cost and quality of life outcomes, TCT 2015, PLATFORM trial

Image courtesy of HeartFlow Inc.

Feature | CT Angiography (CTA) | October 18, 2015
October 18, 2015 — New results from a multicenter, prospective study show that assessing fractional flow reserve...
IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery

Image courtesy of Medtronic

Feature | Peripheral Artery Disease (PAD) | October 18, 2015
October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a drug-coated balloon was superior to...
RESPECT trial, long-term study results, TCT 2015, PFO closure, recurrent cryptogenic stroke

Image courtesy of GE Healthcare

Feature | Stroke | October 16, 2015
October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with...
Amaranth Medical Bioresorbable Scaffold, Fortitude stent
News | Stents Bioresorbable | October 16, 2015
October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials...
Claret embolic protection, TAVR, cerebral protection

The Claret TAVR embolic protection system as seen in the aortic arch under angiography. The loops contain embolic filters they protect the ostium of vessles leading to the brain.

Feature | Heart Valve Technology | October 16, 2015
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at...